The 94th China International Medical Equipment Fair (CMEF) concluded on October 24, 2026, following four days at the Capital International Exhibition & Convention Center in Beijing.
Surgsci Medical Ltd. presented its portfolio across minimally invasive surgery and urology, welcoming healthcare professionals and industry partners to discuss clinical needs, product applications, and opportunities for cooperation.
A Diverse Portfolio Across Surgical and Urological Care
Throughout the exhibition, Surgsci’s booth provided a welcoming setting for professional exchange. Displays spanning surgical instruments, surgical materials, urology products, and CDMO services highlighted the company’s capabilities in product development and manufacturing.
In minimally invasive surgery, featured products included the 2-in-1 Minimally Invasive Surgical Energy Platform, disposable powered endoscopic linear cutting staplers and reloads, disposable laparoscopic trocars, and Locksure® absorbable surgical sutures. Together, these products address key procedural needs in surgical energy, tissue cutting and stapling, laparoscopic access, and tissue closure.
In urology, the MimoPath™ Ureteral Covered Stent System and NanoPath™ Ureteral Stent System highlighted Surgsci’s ongoing work in ureteral stricture management and urological intervention.
The portfolio drew interest from visitors and encouraged discussions about product selection and applications across different clinical settings.
Turning Professional Exchange into Development Insights
Through product displays, hands-on demonstrations, technical discussions, and application presentations, the Surgsci team engaged with clinicians, healthcare institution representatives, distributors, and industry partners from China and abroad.
Visitors shared perspectives on product design, instrument handling, and application requirements, drawing on their local clinical practices, market conditions, and regulatory environments. These face-to-face exchanges strengthened mutual understanding and established a foundation for further cooperation.
Feedback from clinical and commercial settings also provided valuable input for future product development, technical refinement, international collaboration, and service improvement.
Continuing the Conversation Beyond CMEF
Although CMEF 2026 has concluded, the conversations and connections established in Beijing continue.
Guided by its mission of “Improving human health and quality of life,” Surgsci remains committed to understanding clinical needs, advancing product development, and strengthening professional partnerships.
We sincerely thank everyone who visited our booth and shared their insights. We look forward to continuing these discussions and exploring opportunities to work together.
